Last reviewed · How we verify

Orally antibacterial agents

Assistance Publique - Hôpitaux de Paris · FDA-approved active Small molecule

Orally administered antibacterial agents work by inhibiting bacterial growth and survival through various mechanisms such as cell wall disruption, protein synthesis inhibition, or DNA/RNA interference.

Orally administered antibacterial agents work by inhibiting bacterial growth and survival through various mechanisms such as cell wall disruption, protein synthesis inhibition, or DNA/RNA interference. Used for Bacterial infections (oral formulations for systemic or localized infections).

At a glance

Generic nameOrally antibacterial agents
SponsorAssistance Publique - Hôpitaux de Paris
Drug classAntibacterial agent (broad category)
ModalitySmall molecule
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

This is a broad category encompassing multiple classes of oral antibiotics (e.g., fluoroquinolones, macrolides, beta-lactams, tetracyclines) that each target different bacterial structures or processes. The specific mechanism depends on the individual agent within the class, but all function to either kill bacteria directly or prevent their replication, thereby treating bacterial infections.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results